Adjuvant hyperthermic intraperitoneal chemotherapy for adenocarcinoma of the pancreas

  • Stephen E. Ettinghausen
  • Andrew M. Averbach
Part of the Cancer Treatment and Research book series (CTAR, volume 81)


Each year in the United States, approximately 28,000 people develop cancer of the pancreas, resulting in an incidence of 9 cases per 100,000 population [1,2]. Although the incidence of cancers at several other sites is higher, pancreatic carcinoma is the fourth leading cause of cancer death behind malignancies of the lung, prostate, and colorectum in men and cancer of the lung, breast, and colorectum in women [2]. A review of 85 published series encompassing 22,319 patients with pancreatic cancer revealed that only 0.4 percent of patients survived at least 5 years following diagnosis [3].


Gastric Cancer Pancreatic Cancer Peritoneal Carcinomatosis Intraperitoneal Chemotherapy Peritoneal Surface 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Warshaw AL, Fernandez-Del Castillo C. Pancreatic carcinoma. N Eng J Med 1992;326:455–465.CrossRefGoogle Scholar
  2. 2.
    Silverberg E, Lubera JA. Cancer statistics. CA Cancer J 1989;39:3–20.CrossRefGoogle Scholar
  3. 3.
    Gudjonsson B. Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284–2303.PubMedCrossRefGoogle Scholar
  4. 4.
    Warshaw AL, Swanson RS. Pancreatic cancer in 1988. Possibilities and probabilities. Ann Surg 1988;208:541–553.PubMedCrossRefGoogle Scholar
  5. 5.
    Ohta T, Nagakawa T, Ueno K, Kayahara M, Mori K, Kobayashi H, Takeda T, Miyazaki I. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size. Int Surg 1993;78:208–212.PubMedGoogle Scholar
  6. 6.
    Fortner JG. Regional pancreatictomy for cancer of the pancreas, ampulla, and other related sites. Ann Surg 1984;199:418–425.PubMedCrossRefGoogle Scholar
  7. 7.
    Sindelar WF. Clinical experience with regional pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 1989;124:127–132.PubMedGoogle Scholar
  8. 8.
    Nagai H, Kuroda A, Morioka Y. Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material. Ann Surg 1986;204:65–71.PubMedCrossRefGoogle Scholar
  9. 9.
    Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K, Yamaguchi T, Izawa K, Tsunoda T, Yoshino R, Eto T. Collective review of small carcinomas of the pancreas. Ann Surg 1986;203:77–81.PubMedCrossRefGoogle Scholar
  10. 10.
    Manabe T, Tobe T. Progress in the diagnosis and treatment of pancreatic cancer—The Kyoto University experience. Hepatogastroenterology 1989;36:431–436.PubMedGoogle Scholar
  11. 11.
    Arbuck SG. Overview of chemotherapy for pancreatic cancer. Int J Pancreatol 1990;7:209–222.PubMedGoogle Scholar
  12. 12.
    Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358–365.PubMedCrossRefGoogle Scholar
  13. 13.
    Trede M, Schwall G, Saeger HD. Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.PubMedCrossRefGoogle Scholar
  14. 14.
    Camerson JL, Crist DW, Sitzman JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120–125.CrossRefGoogle Scholar
  15. 15.
    Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Tepper J, Nardi G, Suit H. Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973. Cancer 1976;37:1519–1524.PubMedCrossRefGoogle Scholar
  17. 17.
    Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RES, Evans RG. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56–61.PubMedCrossRefGoogle Scholar
  18. 18.
    Mohiuddin M, Cantor RJ, Bierman W, Weiss SM, Barbot D, Rosato FE. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1988;14:79–84.PubMedCrossRefGoogle Scholar
  19. 19.
    Warshaw AL, Tepper JE, Shipley WU. Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg 1986;151:76–80.PubMedCrossRefGoogle Scholar
  20. 20.
    Warshaw AL. Implications of peritoneal cytology for staging of early pancreatic cancer. Am J Surg 1991;161:26–30.PubMedCrossRefGoogle Scholar
  21. 21.
    Billingsley JS, Bartholomeu JG, Childs DS. A study of radiation therapy in carcinoma of the pancreas. Proc Staff Meet Mayo Clinic 1958;33:426.Google Scholar
  22. 22.
    Miller TR, Fuller LM. Radiation therapy of carcinoma of the pancreas. Report on 91 cases. Am J Roentgenol Radium There Nucl Med 1958;80:787.Google Scholar
  23. 23.
    Haslam JB, Cavanaugh PJ, Stroup SL. Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas. Cancer 1973;32:1341.PubMedCrossRefGoogle Scholar
  24. 24.
    Whittington P, Dobelbower RR, Mohiuddin M, Rosato FE, Weiss JM. Radiotherapy of unresectable pancreatic carcinoma: A six year experience with 104 patients. Int J Radiat Oncol Biol Phys 1981;7:1639–1644.PubMedCrossRefGoogle Scholar
  25. 25.
    Kaiser MH, Ellenberg SS. Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985;120:899–903.Google Scholar
  26. 26.
    Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006–2010.CrossRefGoogle Scholar
  27. 27.
    Gastrointestinal Tumor Study Group. A multiinstitutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. Ann Surg 1979;1989:205–208.Google Scholar
  28. 28.
    Gastrointestinal Tumor Study Group. Tratment of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6,000 rads) radiation alone, moderate dose radiation (4,000 radiation + 5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer 1981;48:1705–1710.CrossRefGoogle Scholar
  29. 29.
    Markman M. Intraperitoneal chemotherapy for malignant diseases of the gastrointestinal tract. Surg Gynecol Obstet 1987;164:89–93.PubMedGoogle Scholar
  30. 30.
    Speyer JL. The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol 1985;3:23–28.Google Scholar
  31. 31.
    Markman M, Howell SB. Intraperitoneal chemotherapy: Principles and results of clinical trials. Cancer Treat Res 1987;36:39–59.Google Scholar
  32. 32.
    Markman M. Intraperitoneal chemotherapy. Semin Oncol 1991;18:248–254.PubMedGoogle Scholar
  33. 33.
    Speyer JL, Collins JM, Dedrick RL, Brennan M, Buckpitt AR, Londer H, DeVita VT, Myers CE. Phase I and pharmacologic studies of 5-fluorouracil administered intraperitoneally. Cancer Res 1980;40:567–572.PubMedGoogle Scholar
  34. 34.
    Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I, Meyers CE. Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 1985;98:414–421.PubMedGoogle Scholar
  35. 35.
    Lukas G, Brindle SD, Greengard P. The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Therap 1971;178:562–566.Google Scholar
  36. 36.
    Taylor I, Bennett R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer 1979;39:749–756.Google Scholar
  37. 37.
    Speyer JL. Intraperitoneal chemotherapy: A possible role in the treatment of hepatic metastases. Dev Oncol 1985;30:225–235.Google Scholar
  38. 38.
    Los G, Mutsaers PHA, van der Vijgh WJF, Baldew GS, de Graaf PW, McVie JG. Direct diffusion of cis-diamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: A comparison with systemic chemotherapy. Cancer Res 1989;49:3380–3384.PubMedGoogle Scholar
  39. 39.
    Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–97.PubMedGoogle Scholar
  40. 40.
    Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: Rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 1989;76:1082–1090.PubMedCrossRefGoogle Scholar
  41. 41.
    Goldie JH. Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy. Semin Oncol 1987;14:1–7.PubMedGoogle Scholar
  42. 42.
    Simpson-Heren L, Sanford AH, Holmquist JP. Effects of surgery on the cell kinetics of residual tumor. Cancer Treat Rep 1976;60:1749–1760.Google Scholar
  43. 43.
    Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861–3865.PubMedGoogle Scholar
  44. 44.
    Fisher B, Gunduz N, Saffer EA. Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. Cancer Res 1983;43:1488–1492.PubMedGoogle Scholar
  45. 45.
    Nissen-Meyer R, Kjellgren K, Malmio K, Mansson B, Norm T. Surgical adjuvant chemotherapy: Results with one short course with cyclophosphamide after mastectomy for breast cancer. Cancer 1987;41:2088–2098.CrossRefGoogle Scholar
  46. 46.
    Stanley CJ, Trippet OH, Preston FW. Influence of 5-fluorouracil on wound healing. Surgery 1961;40:450.Google Scholar
  47. 47.
    Morris T. Retardation of healing of large bowel anastomoses by 5-fluorouracil. Aust N Z J Surg 1979;49:743.PubMedCrossRefGoogle Scholar
  48. 48.
    Graf W, Weiber S, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Influence of 5-fluorouracil and folinic acid on colonic healing: An experimental study in the rats. Br J Surg 1992;79:825.PubMedCrossRefGoogle Scholar
  49. 49.
    Graf W, Ivarsgon M, Gerdin B, Hellsing K, Pahlman L, Glimelius B. The influence of early postoperative intraperitoneal chemotherapy on human wound healing. J Surg Res 1994;57:394–400.PubMedCrossRefGoogle Scholar
  50. 50.
    Sugarbaker PH, Cunliffe WJ, Belliveau J, deBruijn EA, Graves T, Mullins RE, Schlag P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989;16:83–89.PubMedGoogle Scholar
  51. 51.
    Esquivel J, Vidal-Jove J, Steves MA, Sugarbaker PH. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631–636.PubMedGoogle Scholar
  52. 52.
    Gerweck LE, Richards B, Jennings M. The influence of variable oxygen concentration on the response of cells to heat or x-irradiation. Radiat Res 1980;85:314–320.CrossRefGoogle Scholar
  53. 53.
    Dewey W, Hopwood L, Sapareto S. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977;123:463–474.PubMedGoogle Scholar
  54. 54.
    Urano M, Gerweck LE, Epstein R. Response of a spontaneous murine tumor to hyperthermia: Factors which modify the thermal response in viro. Radiat Res 1980;83:312–322.PubMedCrossRefGoogle Scholar
  55. 55.
    Dudarte, Jain RK. Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res 1984;44:605–612.Google Scholar
  56. 56.
    Reinhold HS, Endlich BA. Tumor microcirculation as a target for hyperthermia. Int J Hyperthermia 1986;2:111–137.PubMedCrossRefGoogle Scholar
  57. 57.
    Hahn GM. Hyperthermia in Cancer. New York: Plenum Press, 1982.Google Scholar
  58. 58.
    Teicher B, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096–1099.PubMedGoogle Scholar
  59. 59.
    Zakris EL, Dewhirst NW, Riviere JE, Hooper PJ, Page RL, Oleson JR. Pharmacokinetics and toxicity of intraperitoneal cisplatin combined with regional hyperthermia. J Clin Oncol 1987;5:1613–1620.PubMedGoogle Scholar
  60. 60.
    Koga S, Hamazoe R, Maeta M, Shimizu N, Kanayama H, Osak Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res 1984;44:1840–1842.PubMedGoogle Scholar
  61. 61.
    Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, Kiuchi S, Okui K, Miyoshi T, Zrimizu N, Takamizawa H. Ann Surg 1988;208:36–41.PubMedCrossRefGoogle Scholar
  62. 62.
    Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer 1988;61:232–237.PubMedCrossRefGoogle Scholar
  63. 63.
    Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, Takahashi M, Okui K. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198–202.Google Scholar
  64. 64.
    Fijimura T, Yonemura Y, Fushida S, Urade M, Takegawa S, Kamata T, Sugiyama K, Hasegawa H, Katayama K, Miwa K, Miyazaki I. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990;65:65–71.CrossRefGoogle Scholar
  65. 65.
    Fujimoto S, Shrestha RD, Kokubin M, Kobayashi K, Kiuchi S, Konno C, Ohta M, Takahashi M, Kitsukawa Yk, Mizutani M, Chikenji T, Okui K. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg 1990;212:592–596.PubMedCrossRefGoogle Scholar
  66. 66.
    Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutoh T, Ohkubo H. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992;70:2754–2760.PubMedCrossRefGoogle Scholar
  67. 67.
    Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer: Final results of a randomized control study Cancer 1994;73:2048–2052.PubMedCrossRefGoogle Scholar
  68. 68.
    Barlogie B, Corry PM, Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichloradimmineplatinum (11) and mitomycin C. Cancer Res 1980;40:1165–1168.PubMedGoogle Scholar
  69. 69.
    Yonemura Y, Fujimura T, Fushida S, Takegawa S, Kamata T, Katayama K, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15:530–536.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1996

Authors and Affiliations

  • Stephen E. Ettinghausen
  • Andrew M. Averbach

There are no affiliations available

Personalised recommendations